TFA Therapeutics annual depreciation and amortization
2021
2022
2023
2024
2025
TFA Therapeutics Depreciation & Amortization Growth & History (RAJAF)
TFA Therapeutics's depreciation and amortization was $135,243 for fiscal 2025.
View full TFA Therapeutics company overviewTFA Therapeutics annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $135,243 | −$272,022 | −66.79% |
| 2024 | 2024-12-31 | $407,265 | $350,508 | +617.56% |
| 2023 | 2023-12-31 | $56,757 | $32,267 | +131.76% |
| 2022 | 2022-12-31 | $24,490 | −$124,748 | −83.59% |
| 2021 | 2021-12-31 | $149,238 | — | — |
TFA Therapeutics depreciation and amortization trends
Between the periods ended 2021-12-31 and 2025-12-31, TFA Therapeutics's depreciation and amortization decreased from $149,238 to $135,243, a change of −$13,995.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TFA Therapeutics source filings ↗